Hints and tips:
Related Special Reports
...laboratory facilities under an £80mn expansion programme....
...Like wars, pandemics spur innovation and the Northern Irish diagnostics company adapted quickly....
...Campbell hopes the portable diagnostic will transform healthcare by offering a range of fast, cheap tests outside the laboratory, sometimes from just a few drops of blood....
...The papers represented a further “very exciting advance” in the quest to “obtain materials at speeds far surpassing traditional empirical synthesis approaches”, she added....
...At present, the technology, which delivers results within seven to 10 minutes, runs on a benchtop laboratory instrument....
...Patients must have their stem cells extracted from their bone marrow so their genes can be edited in a laboratory....
...In a phase 2b trial of patients with moderate to severe ulcerative colitis, a type of IBD, it improved clinical remission by 36 per cent in 56 weeks, compared with placebo....
...He said chancellor Jeremy Hunt and the health department should address conflicts with the pharmaceutical industry over drug prices and hurdles to running clinical trials in the NHS....
...According to the NHS, 6mn people are now on the waiting list for elective care — all non-urgent medical services ranging from diagnostic tests and scans, to surgery and cancer treatment — up from 4.4mn prior...
...Grail will soon face competition in the US from Datar Cancer Genetics, which inked a $250mn deal last year with US-based diagnostic laboratory company Artemis DNA to fund the rollout of its own MCED test...
...Diagnostic tests — brain scans and/or lumbar punctures — are required to determine eligibility for treatment. And the drug is not a simple chemical but an antibody, expensive to develop and produce....
...Grail is forecast to lose $670mn in 2023 as it funds the largest-ever clinical study of a multicancer detection test in the UK....
...But rather than expanding in the US to try to compete with testing giants such as LabCorp and Quest Diagnostics, Eurofins said it wanted to create “new markets through innovation” in Asia....
...Joshua OfmanWe’ve done, you know, a very robust analytical and clinical validation, and that’s really the requirement to have a diagnostic test or a screening test that’s ready for use in patients....
...An interesting activity is the life quotient, a diagnostic tool based on scores that serve as a check-up, covering areas such as sleep, paid work and your life partner....
...The clinical trial forms part of a six-year collaboration between Merck and Moderna in the field of developing personalised cancer vaccines....
...A late-stage trial of an Alzheimer’s drug set to generate results within weeks is shaping up as a pivotal moment in a three-decade quest to prove that removing sticky amyloid plaques from the brain can slow...
...diagnostics, epidemiology and food safety....
...A smaller 30 microgram dose of the same vaccine boosted antibodies levels 13.5-fold, according to a clinical study of 1,234 participants aged 56 years or older....
...“We’ve seen during the pandemic how quickly diagnostic tests were developed for Covid,” Garner said. “We need to have a similar approach for AMR....
...William Morice, president of the American Clinical Laboratory Association, said such fluctuations make it difficult for manufacturers to sustain peak production....
...Each member becomes part of an ongoing clinical trial that promises to pioneer our understanding of how to “de-age”....
...According to an often-quoted study published in the British Journal of Clinical Pharmacology in 2018, only 22 per cent of subjects in Phase 1 drug trials are female....
...Quest Diagnostics said average turnround times for results had blown out from within 24 hours to two to three days because of the Omicron surge....
...“Some pharmacy-based testing may be complementary to clinical laboratory testing, but not disruptive,” said Edward Ashwood, professor and vice chair for clinical pathology at the University of Colorado School...
International Edition